Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intracoronary stenting and angiographic results: Test efficacy of 3 limus-eluting stents (ISAR-TEST 4): Prospective, randomized trial of 3-limus agent-eluting stents with different polymer coatings.

Next Previous
Trial Profile

Intracoronary stenting and angiographic results: Test efficacy of 3 limus-eluting stents (ISAR-TEST 4): Prospective, randomized trial of 3-limus agent-eluting stents with different polymer coatings.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sirolimus (Primary) ; Everolimus
  • Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms ISAR-TEST-4

Most Recent Events

  • 01 Jul 2022 Results (n=4953) of a post-hoc analysis assessing target and non-target vessel related events at 10 years from two clinical studies: NCT00598676 and NCT00598533 published in the Clinical Research in Cardiology
  • 07 Dec 2015 Pooled analysis results of propensity-matched analysis from DESSOLVE I, DESSOLVE II and ISAR-TEST-4 study published in the American Journal of Cardiology.
  • 19 May 2015 Retrospective patient level propensity-matched analysis, comparing data from the DESSOLVE I and DESSOLVE II compared to ISAR-TEST-4 study, presented at the official congress of European Association of Percutaneous Cardiovascular Interventions, as reported by Micell Technologies media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top